Latest 5 articles from heartwire
- Interventional cardiologist Donald Baim dies
Nov 06, 2009 18:22 EDT - Latest European and US STEMI guidelines compared and contrasted
Nov 06, 2009 17:15 EDT - Enrollment halts in randomized trial of CPR for out-of-hospital arrest
Nov 06, 2009 16:00 EDT - Medicaid access to smoking cessation falls short
Nov 05, 2009 17:30 EDT - Serum phosphorous, kidney function predict CAC
Nov 05, 2009 17:00 EDT
Board recertification: Do's and don'ts
Posted Jun 26, 2009
at 09:48 AM, EDT
by Seth Bilazarian
Studying for board recertification is a challenging and sometimes laborious process for any busy clinician and one that can provoke a spectrum of emotions from paranoia (will I pass?) to anger (what an incredible burden!) to euphoria (it's over!).
What are your strategies for this daunting process? Do you go it alone or use a study partner? Have you used online resources or are you by-the-book? Beyond practicalities, what are your thoughts on the actual process? Is it possible to fine-tune the system to limit the burden for the practitioner?
See:
The American board of internal medicine website with information on the certification process
2008 Interventional Cardiology Overview and Board Preparatory Course
Previous postsBillets précédents
Glossy job listings in a hostile healthcare environment
No commentsAucun commentaire |
Posted Oct 28, 2009
at 03:30 PM, EDT by Seth Publié le 10.28.2009 à 15h30 par Seth
at 03:30 PM, EDT by Seth Publié le 10.28.2009 à 15h30 par Seth
Passwords and network security: Is more "less"?
No commentsAucun commentaire |
Posted Oct 21, 2009
at 10:30 AM, EDT by Seth Publié le 10.21.2009 à 10h30 par Seth
at 10:30 AM, EDT by Seth Publié le 10.21.2009 à 10h30 par Seth
From femoral to radial access for PCI: Practical tips and observations for the community based interventional practitioner
No commentsAucun commentaire |
Posted Oct 14, 2009
at 10:45 AM, EDT by Seth Publié le 10.14.2009 à 10h45 par Seth
at 10:45 AM, EDT by Seth Publié le 10.14.2009 à 10h45 par Seth
RE-LY: Patient preference based on the data
No commentsAucun commentaire |
Posted Sep 11, 2009
at 10:05 AM, EDT by Seth Publié le 09.11.2009 à 10h05 par Seth
at 10:05 AM, EDT by Seth Publié le 09.11.2009 à 10h05 par Seth
DNR patient with STEMI = To PCI or not?
1 comment1 commentaire |
Posted Sep 04, 2009
at 10:50 AM, EDT by Steven Publié le 09.04.2009 à 10h50 par Steven
at 10:50 AM, EDT by Steven Publié le 09.04.2009 à 10h50 par Steven
Also from theheart.org
About Dr Seth Bilazarian
Seth Bilazarian MD has been a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts since 1993. He is board certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine.
Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.
Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.
Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
About this blog
My intent is to create a forum for dialogue on issues pertinent to private practice cardiology around topics such as:
- Integration of new data and guidelines on inpatient and outpatient practice in clinical and interventional cardiology
- Practice approaches to the extra clinical issues in dealing with managed care insurers
- Strategies for navigating the restrictions of pharmacy benefits managers (PBMs) on pharmacologic therapies for our patients
- Experiences with restrictions on testing and imaging














CommentsCommentaires